Fulgent Genetics Launches NGS Test to Detect Covid-19
Fulgent Genetics partners with MedScan Laboratory to launch one of the market’s first covid-19 tests based on next-generation sequencing technology.
Read MoreSearch Results for: genetic testing
HHS Supports Development of High-Throughput Molecular Diagnostic for COVID-19
A COVID-19 diagnostic designed for use on a system that can process up to 1,000 tests in 24 hours will receive advanced development support from an HHS BARDA grant.
Read More
OGT Releases NGS Panel for Somatic CNV Detection in Chronic Lymphocytic Leukemia
The panel has been tested to show excellent concordance with array data, and can detect both small and large CNVs, indels, LOH, and SNVs.
Read MoreCepheid and Sherlock Biosciences Establish Collaboration on New GeneXpert Tests for Infectious Diseases and Oncology Leveraging CRISPR Technology
The collaboration will focus on molecular diagnostic tests for infectious diseases and oncology, beginning with a proof-of-concept project focused on detection of coronavirus (SARS-CoV-2).
Read MoreFDA Authorizes Marketing of the First Genetic Test to Aid in the Diagnosis of Fragile X Syndrome
The test can determine whether a patient has a number of CGG repeats that is considered either normal, intermediate, premutation, or full mutation.
Read More